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Edited by Vladimir SkulachevAbstract Pleiotropic effects in the oxidative phosphorylation
pathway (OXPHOS) were investigated in yeast respiratory mu-
tants and in cells from patients with OXPHOS genetic altera-
tions. The main differences between yeast and human cells
were (1) the site of the primary defect that was associated with
pleiotropic effects, yeast complex V and human complex IV,
and (2) the nature of the complex targeted by the secondary ef-
fect, yeast complex IV and human complex I. The pleiotropic ef-
fects did not correlate with the organization of OXPHOS into
supercomplexes and their functional consequences appeared to
be a slowing down of the respiratory chain in order to avoid
either an increase in the membrane potential or the accumulation
of reduced intermediary components of the respiratory chain.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Homo sapiens1. Introduction
The mitochondrial respiratory chain (complexes I to IV)
couples electron transfer to the generation of a proton gradi-
ent, which is then dissipated via complex V (ATP synthase)
to produce ATP. In mammals and plants, the electron transfer
chain comprises NADH quinone oxidoreductase (complex I),
succinate quinone oxidoreductase (complex II), ubiquinol
cytochrome c oxidoreductase (complex III) and cytochrome
c oxidase (complex IV). In the yeast Saccharomyces cerevisiae,
complex I is absent and replaced by three NADH dehydro-
genases.
The association of respiratory complexes in larger order
structures named supercomplexes has been demonstrated by
the use of mild detergents, such as digitonin, and blue native
gel electrophoresis (BN-PAGE) [1,2] for review. In mammals
and plants, supercomplexes formed by complexes I and III,
and by complexes I, III and IV have been described. The struc-
ture of the supercomplex I + III2 of Arabidopsis at a resolution
of 18 Å has been obtained [3]. In yeast, supercomplexes III–IV
and a dimer of ATP synthase have been visualized by electron
microscopy [4,5], the latter being important for the formation
of cristae [6]. According to the solid state model (see [7] for re-*Corresponding author. Fax: +33 (0) 1 69 82 31 60.
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that alteration of one of the respiratory complexes could affect
the stability of other respiratory complexes. Indeed, such pleio-
tropic effects have been observed with complex III and V de-
fects in S. cerevisiae [8–10] and with cytochrome b and
COX10 defects in mammals [11,12]. To determine if the pleio-
tropic effects are governed by specific rules, we undertook an
analysis of 12 yeast mutants and 9 human skin fibroblasts with
diverse defects in the OXPHOS by combining BN-PAGE anal-
ysis, cytochrome spectrum recordings and OXPHOS activity
measurements. The yeast mutants carried deletions of either
a gene encoding an assembly factor (BCS1 for complex III;
SHY1, SCO1 and SCO2 for complex IV) or a structural gene
of a respiratory complex subunit (CYT1, RIP1 and COR1 for
complex III; COX4 and COX9 for complex IV and ATP1,
ATP2 and ATP15 for complex V). The Datp1, Datp2 and
Datp15 mutants were all altered in a structural subunit of F1
but the Datp15 mutant is the only one to exhibit a proton leak-
age [13]. The human fibroblasts had alterations in either a
structural gene (ND5 and NDUFS4 for complex I and ATP6
for complex V) or an assembly protein (BCS1 for complex
III and SURF1 and SCO2 for complex IV). The gene SURF1
is the human homolog of the yeast gene SHY1.2. Materials and methods
Saccharomyces strains Drip1, Dbcs1, Dcyt1, Dcor1, Dcox4, Datp2
and Datp15 were in the W303 nuclear background (MATa ade2-1
ura3-1 his3-11, 15 trp1-1 leu2-3,112 can1-100). Strains Dsco1, Dsco2,
Dshy1, Dcox9 and Datp1 were from Euroscarf and were derived from
the strain BY4742 (MATa; his3D1; leu2D0; lys2D0; ura3D0). The
strains were grown in complete galactose medium (YPGAL) and yeast
mitochondria were prepared by differential centrifugations as de-
scribed in [14]. The production of petite mutants with either absence
(rho0 mutants) or deletion (rho-mutants) of their mitochondrial
genomes, was systematically checked by crossing the cells to a rho0
strain and testing the growth of the diploids on non-fermentable
substrate. This was important as petite accumulation would lead to a
non-specific pleiotropic effect on complexes III, IV and V.
Human skin fibroblasts were derived from forearm skin biopsies
according to routine procedures and cultured in 4.5 g/L glucose
DMEM medium with 10% fetal calf serum, 200 lM uridine and
1 mM pyruvate. Patients age at diagnosis, clinical presentation and ge-
netic alteration are summarized in Table 1.
The respiratory chain activities of cultured skin fibroblasts were ana-
lyzed by ATP measurement, polarography and spectrophotometric as-
says as reported in [15]. BN-PAGE was carried out according to
Schagger and von Jagow [16] with slight modifications as described
in [14] and was used for the separation of the respiratory complexes
on 5–10% or 6–15% polyacrylamide gradient gels. Yeast mitochondria
were solubilized either with 2% digitonin or 2% lauryl maltoside.blished by Elsevier B.V. All rights reserved.
Table 1
Age at diagnosis, clinical presentation and genetic alterations of the patients from whom the skin fibroblasts were derived
Patient Age at diagnosis Clinical presentation Genetic cause
hI-1 (M) 3 months Leigh syndrome NDUFS4 c.358 + 1G > A, hmz
hI-2 (F) 3 months Leigh syndrome MT-ND5 m.13513G > A, proportion >95%
hIII-1 (F) 1 month Multi-visceral failure BCS1 c.830G > A, p.ser277asp, hmz
hIV-1 (F) 48 months Leigh syndrome SURF1 c.842T > C, p.2leu281pro and c.55 + 31_delTGCGGGG, hmz
hIV-2 (F) 12 months Leigh syndrome SURF1 c.312delTCTGCCAGCCinsAT and c.752-3C < G
hIV-3 (M) 12 months Leigh syndrome SURF1 c.370G > A p.gly124arg and c.588+1G > A and c.752-3C < G
hIV-4 (M) 1 month Cardiopathy, hypotonia Sco2 c.423G > A, p.glu140lys and c.511C > T, p.arg171trp
hV-1 (F) 35 years Leigh syndrome MT-ATP6 m.8993T > C, proportion >95%
hV-2 (F) 10 years Leigh syndrome MT-ATP6 m.8993T > C, proportion >95%
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[17]. Western blots of blue native gels were performed as described in
[14] using polyclonal antibodies against human Nd1p (complex I) and
against human Cox2p (complex IV) produced in the laboratory of Dr.
A. Lombès, against human Core2p (complex III) kindly provided by
Dr. C. Godinot (CGMC, Lyon, France), against the yeast b subunit
(complex V) kindly provided by Dr J. Velours (IBGC, Bordeaux,
France), against yeast Cyt1p (complex III) produced by Dr. C. Lem-
aire and Dr. G. Dujardin, and against yeast Cox6p (complex IV)
kindly provided by Dr. R. Poyton (University of Colorado, BO,
USA). The antibodies against human 70 kDa (complex II) were mono-
clonal antibodies from Molecular Probes. Immunodetection was car-
ried out using enhanced chemiluminescence method (SuperSignal
West Pico Chemiluminescent Substrate for yeast and SuperSignal West
Femto Maximum Sensitivity Substrate for human fibroblasts, Pierce)
and the relative amount of the different respiratory complexes was
quantified using the software Multigauge provided with the LAS
3000 imaging system (Fuji).Fig. 1. Blue-Native PAGE analysis of respiratory complexes in yeast
mitochondria. Mitochondria were solubilized with either digitonin
(panel A) or n-dodecyl maltoside (panel B). Blue Native polyacryl-
amide gels were either stained with colloidal blue (panel A) or proteins
were transferred onto nitrocellulose and immunodetected with specific
polyclonal antibodies (panel B): anti- yeast Cyt1p for complex III (III),
anti- yeast Cox6p for complex IV (IV) and anti-b subunit for complex
V (V). V1 and V2 correspond to the monomers and dimers of complex
V respectively; III2: dimers of complex III; IV1 and IV2: monomers and
dimers of complex IV; *: supplementary band of about 500 kDa
observed only in III-1 mutants.3. Results and discussion
3.1. Supramolecular organization and respiratory complex
steady-state in yeast mutants
Mitochondria were purified from 12 yeast mutants of com-
plexes III, IV and V and the supramolecular organization of
the three respiratory complexes was first analyzed by BN-
PAGE after digitonin solubilization to preserve the interac-
tions between complexes (Fig. 1A). The wild-type strain (wt)
showed the previously reported supramolecular organization
[1] comprising four main bands corresponding to the complex
V dimers (V2), supercomplexes III2 + IV2 and III2 + IV1 and
complex V monomers (V1). All complex III mutants (patterns
III-1 and III-2) lacked the supercomplexes III2 + IV2 and
III2 + IV1. In addition, Drip1 and Dbcs1 (pattern III-1) dis-
played a supplementary band of about 500 kDa (absent in
Dcyt1 and Dcor1, pattern III-2) that was recognized by the
antibodies against Cyt1p (data not shown) and might cor-
respond to the dimeric complex III assembly intermediate
lacking the FeS protein [18]. For complex IV mutants, as ex-
pected [19] the Dsco2 strain showed a wild type pattern
whereas Dshy1, Dsco1 and Dcox9 strains showed combined de-
fects in supercomplexes III2 + IV2 and III2 + IV1 (pattern IV).
Finally, for complex V mutants, the Datp1 and Datp2 mutants
displayed an absence of complex V dimers and monomers, as
expected, but also of supercomplexes III2 + IV2 and III2 + IV1
(pattern V-1) whereas the Datp15 mutant displayed a reduced
amount of complex V dimers and monomers, and no major ef-
fect on the amount of supercomplexes III2 + IV2 and
III2 + IV1 (pattern V-2).
In conclusion, the analysis of the supramolecular organiza-
tion of respiratory complexes in these mutants showed that
the deficiency of each respiratory complex induced the reduc-
tion in the supercomplexes to which it participates. Two com-
plex V mutants also showed a pleiotropic effect on the steady
state level of supercomplexes III2 + IV2 and III2 + IV1.
In order to determine if this effect was due to a defect in the
supramolecular organization or to a specific lack of complex
III or IV, we then checked the steady-state level of the respira-
tory complexes III, IV and V after solubilization of the mito-
chondria with laurylmaltoside, which allows separation of
the different complexes. As shown in Fig. 1B, complex III or
IV mutants had normal steady-state levels of the other com-
plexes (IV and V or III and V, respectively). In addition, Drip1
and Dbcs1 complex III mutants (pattern III-1) showed a stable
complex III assembly intermediate, which corresponded to the
supplementary band observed in BN-PAGE (see above). In
striking contrast, in addition to the absence of complex V,
the Datp1 and Datp2 mutants (Fig. 1B, pattern V-1) showed
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The absence of supercomplexes III2 + IV2 and III2 + IV1 ob-
served in these mutants (Fig. 1A, pattern V-1) appeared there-
fore to be due to the defect of complex IV. In agreement with
BN-PAGE data, the Datp15 mutant (Fig. 1B, pattern V-2)
showed a partial decrease in complex V (F0F1 and F1) but
no major effect on the amount of complexes IV and III.
In conclusion, in yeast, pleiotropic effects are observed only
in two complex V mutants, which exhibited combined deficien-
cies in complexes V and IV. These major effects do not seem to
be related to the supramolecular organization as no interaction
between complexes IV and V has been reported until now.
Alterations of complex IV have been previously described in
other ATPase mutants (Datp4 [20], Datp17 [21], Datp8 [22] or
Datp9 [23]). In these mutants however a high level of petite
production renders the interpretation difficult. Petite produc-
tion has been shown to be less than 1% in Datp1 and Datp2 mu-
tants [24]. We have checked that in our conditions the petite
production was also less than 1% and thus cannot explain
the observed combined defect. A Datp6 mutant with restricted
petite accumulation has also been recently constructed [10]; it
showed a significant decrease in the accumulation of complex
IV related to a failure in the synthesis of Cox1p. The sole atp
mutant (Datp15), which does not affect complex IV, exhibits a
proton leakage [13]. We therefore hypothesized that reduction
of the amount of complex IV would be observed only in com-
plex V mutants unable to dissipate the proton gradient. In or-
der to test this hypothesis, we analyzed complex IV assembly
in cells treated with oligomycin, a known blocker of proton
translocation. As shown in Fig. 2, wild-type yeast grown in
the presence of oligomycin exhibited a strong decrease of cyto-
chromes a and a3 and a slight effect on the levels of cyto-
chromes c1 and b similar to the decreases observed in the
Datp2 mutant. We have checked that the petite production in
our growth condition was only 10%. When cells were returned
to an oligomycin-free medium, the steady-state level of cyto-Fig. 2. Cytochrome spectra of oligomycin treated cells. Cells were
grown for 15 h on liquid YPGAL medium. Wild-type strain (wt) and
Datp2 mutant were grown without oligomycin. The wild-type strain
grown with 3 mg per liter of oligomycin (wt + oligo) was rediluted in
an oligomycin-free medium and grown again for 15 h (wt  oligo).
Cytochrome spectra were recorded after reduction by dithionite using
a Cary 400 spectrophotometer. Cytochromes a and a3 are part of
complex IV and cytochromes b and c1, of complex III. Absorption
maxima of cytochromes c, c1, b and a + a3 are 546, 552, 558 and
602 nm, respectively.chromes a and a3 returned to normal (Fig. 2) showing that
the decrease was reversible and therefore not due to secondary
adaptative mutations. Blocking proton translocation thus in-
duces a defect in complex IV and consequently a decrease of
the proton gradient, which might serve to prevent the building
up of a too high membrane potential.
3.2. Steady-state of the OXPHOS complexes I, II, III, IV and V
in human cells
The low content of OXPHOS complexes in cultured skin
fibroblasts makes immunoblotting a necessary approach to
analyze isolated complexes solubilized by laurylmaltoside
and separated by BN-PAGE. As most patients with OXPHOS
genetic alterations were young children we always used the
same control cells originating from a one year old girl skin
biopsy. We analyzed the steady-state amount of complexes I
to V in nine different fibroblast lines derived from patients with
diverse genetic OXPHOS alterations (Table 1). Oxygen con-
sumption, ATP production and complexes II, III, IV and V
activity were also systematically measured. Complex II activity
was normal in all the cells. The amount of complex II was sub-
sequently used as a control for the amount of mitochondrial
proteins. The results of immunoblotting experiments and sig-
nificant alterations in activity are presented in Fig. 3. Two cell
lines (hI-1 and hI-2) had alterations in structural subunits of
complex I associated with a severe defect in oxygen consump-
tion and ATP production from complex I substrates (pyru-
vate + malate or glutamate + malate) but normal activities
using a complex II substrate (succinate + rotenone) (Fig. 3, pa-
nel complex I). BN-PAGE analysis of these cells showed alter-
ations only in complex I: abnormal electrophoretic mobility in
both cells and a 40% reduction in the amount of complex I in
cells hI-2. Cells hIII-1 carried an altered BCS1 gene. They did
not show a significant decrease in complex III activity in agree-
ment with previous reports [25,26]. However, these cells,
showed a partial but significant reduction in the steady-state
level of complexes I and V (Fig. 3, panel complex III), which
strengthened the relevance of the partial decrease in the rates
of oxygen consumption and ATP synthesis observed with these
cells, which on their own were not statistically significant.
Four cell lines had altered genes encoding assembly factors
of complex IV: SURF1 (hIV-1, hIV-2 and hIV-3) or SCO2
(hIV-4). As expected, the amount of complex IV was severely
reduced in these cells and correlated with the decrease in com-
plex IV activity and oxygen consumption (Fig. 3, panel com-
plex IV). In addition, three of the four cell lines showed a
decreased steady-state amount of other respiratory complexes,
which included complex I in the three cases as well as complex
III in hIV-3 and complex V in hIV-4. The two cells lines with
an altered complex V (hV-1 and hV-2, Fig. 3 panel complex V)
had an identical mutation in the MT-ATP6 gene. Both cell
lines had reduced amount of complex V and this was asso-
ciated with a reduced amount of complexes I and IV in one
case (hV-1). However the hV-1 cell line was the only one de-
rived from an adult patient (Table 1) and the observed reduc-
tion could have been related to difference of age between the
patient and the control cells.
In conclusion, pleiotropic effects were observed in several
fibroblasts lines defective for complex IV and in one line defec-
tive for bcs1. They were absent in complex I defective cell lines.
Definite conclusions could not be reached with complex V de-
fects but the absence of pleiotropic effects in the most severely
Fig. 3. Blue-Native PAGE analysis of respiratory complexes and activities in human cultured skin fibroblast mitochondria. Fibroblast mitochondria
(40 lg protein) from control (C) and several patients were separated by BN-PAGE 5–10% polyacrylamide gradients for the analysis of complexes I
and V, or on 6–15% polyacrylamide gradients for the analysis of complexes II, III and IV. Proteins were transferred onto nitrocellulose and
immunodetected with anti-Nd1p subunit for complex I (CI), anti-70 kDa subunit for complex II (CII), anti-Core2p for complex III (CIII), anti-
Cox2p for complex IV (CIV) and anti-b subunit for complex V (CV). The dashed line indicates the electrophoretic mobility of complex I in the
control. Quantification of each complex is expressed as a percentage of the control below the line. Significant modifications are boxed and noted in
bold. Oxygen consumption, ATP production and CIV activity are expressed as a percentage of the control. Oxygen consumption and ATP
production were measured using either complex I substrates (pyruvate + malate or glutamate + malate, results shown as grey bars) or the complex II
substrate (succinate + rotenone, results shown as hatched bars).
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important for diagnosis as they show that a concomitant alter-
ation of complexes I and IV could be an indicator of a primary
defect on complex IV assembly. The mechanisms underlying
these pleiotropic effects remain to be clarified. As in yeast, they
do not seem to be related to supercomplexes, as we have not
observed any concomitant decrease in the complexes I, III
and IV that are associated together. Again, as in yeast, these
observations are compatible with the hypothesis that human
cells employ mechanisms to slow down electron transfer and/
or to limit the membrane potential in the presence of certain
OXPHOS defect. Targeting complex I in human cells might
also have a major effect on the production of reactive oxygenspecies by decreasing the steady-state of reduced intermediary
components of the respiratory chain. This difference could sug-
gest that the physiological phenomenon underlying the regula-
tion may be different between yeast and humans especially as
S. cerevisiae does not have complex I.
In conclusion, the pleiotropic effects of an isolated OXPHOS
alteration may be observed in man as in S. cerevisiae and they
do not seem to correlate with the organization of OXPHOS
complexes into supercomplexes. The functional consequences
of the pleiotropic effects appear to be the slowing down of
the respiratory chain in order to prevent either a too high
membrane potential or the accumulation of reduced intermedi-
ary components of the respiratory chain.
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